Shana Arnhold, PA
Medical · Shawnee, KSNPI 1811189327
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $50,730 of the $81,881 with a category attached, or 62.0%. AbbVie accounts for 61.6% of it on its own, with 37 other manufacturers making up the rest. Among medical clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 687 payments — averaging $119.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$50K
- Takeda Pharmaceuticals U.S.A., Inc.$20K
- Janssen Scientific Affairs, LLC$6K
- Johnson & Johnson$1K
- Lilly USA, LLC$438
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$418
- plus $4K from 32 others
What the payments were for
- Consulting fees$4,3285%
- Speaking & faculty fees$50,73062%
- Travel & lodging$14,48318%
- Food & beverage$12,28815%
- Education$520%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$81,881 in reported general payments places this provider in the 95th percentile of 205 medical providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 20 | $209,225 |
| Mesalamine | 26 | $5,919 |
| Colestipol Hcl | 32 | $1,956 |
| Lubiprostone | 11 | $1,106 |
| Lactated RingersRinger's Solution,lactated | 26 | $1,023 |
| Pantoprazole Sodium | 121 | $821 |
| Sucralfate | 12 | $793 |
| Omeprazole | 67 | $598 |
| Famotidine | 65 | $395 |
| Esomeprazole Magnesium | 18 | $264 |
| Ondansetron OdtOndansetron | 22 | $253 |
| Metformin Hcl | 11 | $42 |
| Citalopram HbrCitalopram Hydrobromide | 11 | $9 |
Paid to pharmacies, not to this prescriber.
Other medical in Shawnee
- Linly StevensOverland Park$111K
- Richard AllenbachWichita$70K
- Laura LudlowTopeka$61K
- Anita KishOlathe$58K
- Kathryn WelchWichita$32K
- Courtney SteneOverland Park$22K
- Janella DewittOverland Park$19K
- Walter DeanMission$16K
- Jason MengesWichita$15K
- Trang BrownleeWichita$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.